Inhibitory Effect of a Protease Inhibitor, Leupeptin, on the Development of Influenza Pneumonia, Mediated by Concomitant Bacteria

References

1. Aoyagi T. A., Umezawa H. 1975; Structures and activities of protease inhibitors of microbial origin. In Proteases and Biological Control pp. 429–454 Reich E., Rifkin D. B., Shaw E. Edited by New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
2. Klenk H.-D., Rott R., Orlich M., Blödorn J. 1975; Activation of influenza A viruses by trypsin treatment. Virology 68:426–439
   [Google Scholar]
3. Lazarowitz S. G., Choppin P. W. 1975; Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68:440–454
   [Google Scholar]
4. Rott R., Klenk H.-D. 1986; Pathogenicity of influenza virus in model systems. In Options for the Control of Influenza pp. 53–62 Kendal A. P., Patriarca P. A. Edited by New York: Alan R. Liss;
   [Google Scholar]
5. Stuart-Harris C. H., Schild G. C., Oxford J. S. 1985 Influenza: The Viruses and the Disease, 2nd Edn. London: Edward Arnold;
   [Google Scholar]
6. Tashiro M., Ciborowski P., Klenk H.-D., Pulverer G., Rott R. 1987a; Role of Staphylococcus aureus in the development of influenza pneumonia. Nature; London: 325536–537
   [Google Scholar]
7. Tashiro M., Ciborowski P., Reinacher M., Pulverer G., Klenk H.-D., Rott R. 1987b; Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology 157:421–430
   [Google Scholar]
8. Zhirnov O. P., Ovcharenko A. v., Bukrinskaya A. G. 1982; Proteolytic activation of influenza WSN virus in culture cells is performed by homologous plasma enzymes. Journal of General Virology 63:469–474
   [Google Scholar]
9. Zhirnov O. P., Ovcharenko A. v., Bukrinskaya A. G. 1984; Suppression of influenza virus replication in infected mice by protease inhibitors. Journal of General Virology 65:191–196
   [Google Scholar]